Gadoterate meglumine(Dotarem®),Gadobutrol(Gadovist® - Gadavist®) andGadoteridol(Prohance®) are the threeGBCAswhich should be used in neuroimaging. When both MRI and gadolinium injection are clinically indicated, there are no absolute contraindications for GBCAs injection, and prior laboratory...
阅读量: 863 作者: 韩晓丹 展开 摘要: 钆特酸葡甲胺(gadoterate meglumine)注射液是法国加柏(Guerbet)公司开发的一种以元素钆为基础的造影剂(GBCA),于2013年3月20日获美国FDA批准在美国上市,商品名为Dotarem,该药用于年龄在2岁及以上患者的脑,脊柱和相关组织的磁共振成像(MRI)[1]. 展开 年份: 2013 收...
FDA Approved: Yes (First approved March 20, 2013)Brand name: DotaremGeneric name: gadoterate meglumineDosage form: InjectionCompany: GuerbetTreatment for: Diagnosis and InvestigationDotarem (gadoterate meglumine) is a gadolinium-based contrast agent indicated for use in magnetic resonance imaging (MRI)....
Objective To assess the safety of gadoterate meglumine (Dotarem) in patients younger than 2 years of age by evaluating adverse events following contrast administration. Materials and methods Pediatric patients younger than 2 years of age undergoing magnetic resonance imaging (MRI) with and without ...
Journals & Books Help Search My accountSign inGadoterate Meglumine In subject area: Pharmacology, Toxicology and Pharmaceutical Science Featured on this page Chapters and Articles You might find these chapters and articles relevant to this topic....
Life-threatening anaphylactoid reaction after iv injection of gadoterate meglumine. MEULI A. & MAEDER P.: Life-threatening anaphylactoid re- action after iv injection of gadoterate meglumine. AJR 166 (1996), 729... RA Meuli,P Maeder - 《Ajr American Journal of Roentgenology》 被引量: 34发表:...
Two cases ofanaphylactic shockafter first exposure togadoteratemeglumine (Gd-DOTA;Dotarem; Guerbet, Roissy, France) have been reported [27A], with the implication that the tetra-azacyclododecane derivative ligand of macrocyclic MRI contrast agents are involved in the genesis ofanaphylactic reactions, as...
To evaluate whether dynamic contrast enhanced (DCE) MRI with a split injection of 30% followed by 70% of a standard dose (30PSD and 70PSD) of gadoterate meglumine (DOTAREM) can improve diagnosis of prostate cancer (PCa).#MRI for twenty patients was performed on a Philips Ingenia 3T ...